Atıf Formatları
Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. Ozgul Et Al. , "Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches," NEUROCHEMISTRY INTERNATIONAL , vol.85-86, pp.1-13, 2015

Ozgul, S. Et Al. 2015. Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches. NEUROCHEMISTRY INTERNATIONAL , vol.85-86 , 1-13.

Ozgul, S., KASAP, M., AKPINAR, G., KANLI, A., Guzel, N., Karaosmanoglu, K., ... BAYKAL, A. T.(2015). Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches. NEUROCHEMISTRY INTERNATIONAL , vol.85-86, 1-13.

Ozgul, Sinem Et Al. "Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches," NEUROCHEMISTRY INTERNATIONAL , vol.85-86, 1-13, 2015

Ozgul, Sinem Et Al. "Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches." NEUROCHEMISTRY INTERNATIONAL , vol.85-86, pp.1-13, 2015

Ozgul, S. Et Al. (2015) . "Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches." NEUROCHEMISTRY INTERNATIONAL , vol.85-86, pp.1-13.

@article{article, author={Sinem Ozgul Et Al. }, title={Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches}, journal={NEUROCHEMISTRY INTERNATIONAL}, year=2015, pages={1-13} }